article thumbnail

Procyrion Announces First Patient Enrollments in the DRAIN-HF Pivotal IDE Trial for Aortix Percutaneous Mechanical Circulatory Support Technology

DAIC

The company recently announced it has received CMS approval for Medicare coverage during the DRAIN-HF pivotal trial. For more information: www.procyrion.com If you enjoy this content, please share it with a colleague

article thumbnail

Cardiac resynchronization therapy (CRT) – why is it so important?

Cardiomatics

Cardiac resynchronization therapy (CRT) exists as an option for patients with heart failure with reduced ejection fraction (HFrEF), for whom pharmacotherapy alone is insufficient to reduce symptoms and control cardiac function [2]. Heart Fail. 2012, 14, 628–634. [5] 5] Bilchick, K.C.; Circulation 2010, 122, 2022–2030. [6]